Publication & Citation Trends
Publications
0 total
Activity of ceftolozane/tazobactam and imipenem/relebactam against clinical isolates of Enterobacterales and Pseudomonas aeruginosa collected in Greece and Italy—SMART 2017–2021 OA
Cited by 4
Semantic Scholar
Carbapenem resistance among Gram-negative isolates collected from patients in ICU and non-ICU hospital wards in Hong Kong: SMART 2017-2020. OA
Cited by 2
Semantic Scholar
Epidemiology and in vitro activity of ceftazidime-avibactam and comparator agents against multidrug-resistant isolates of Enterobacterales and Pseudomonas aeruginosa collected in Latin America as part of the ATLAS surveillance program in 2015‒2020 OA
Cited by 10
Semantic Scholar
2128. In Vitro Activity of Ceftibuten-Avibactam and Comparator Agents Against Resistant Enterobacterales from UTIs Collected Globally as Part of the ATLAS Surveillance Program, 2022 OA
Cited by 0
Semantic Scholar
2153. Addition of Relebactam Increases Susceptibility to Imipenem Alone against Class C β-lactamase-Positive Enterobacterales: Asia/Pacific SMART 2019-2021 OA
Cited by 0
Semantic Scholar
In vitro activity of ceftolozane/tazobactam against multidrug-resistant Pseudomonas aeruginosa from patients in Western Europe: SMART 2017-2020.
Cited by 15
Semantic Scholar
2119. In Vitro Activity of Aztreonam-Avibactam Against Enterobacterales Isolated from Pediatric and Adult Patients Collected During the ATLAS Global Surveillance Program, 2017-2021 OA
Cited by 0
Semantic Scholar
Susceptibility of gram-negative isolates collected in Taiwan to imipenem/relebactam and comparator agents - SMART 2018-2021. OA
Cited by 4
Semantic Scholar
Research Topics
Antibiotic Resistance in Bacteria
(262)
Antibiotics Pharmacokinetics and Efficacy
(196)
Antibiotic Use and Resistance
(171)
Pneumonia and Respiratory Infections
(82)
Bacterial Identification and Susceptibility Testing
(82)
Affiliations
Allegheny College
Barnes-Jewish Hospital
St. Louis Children's Hospital
University of Freiburg
Pfizer (United States)